Literature DB >> 24618297

In vivo environment necessary to support transplanted donor mouse T regulatory cells.

C Cabello-Kindelan1, A de la Barrera, T R Malek, A L Bayer.   

Abstract

CD4(+) Foxp3(+) T regulatory cells (Tregs ) are essential for maintaining immunological tolerance, which could be harnessed for novel cell-based therapies to prevent allograft rejection and control autoimmunity. However, the use of Tregs for therapy is hindered by the inability to generate sufficient cell numbers to inhibit desired immune response(s) and achieve stable engraftment of the donor-Treg cell inoculums. The present study was undertaken to investigate the in vivo requirements to promote engraftment of adoptively transferred Tregs and induce tolerance. We established that not only is peripheral space required, but competition from endogenous Tregs must be minimized for successful donor-Treg engraftment with IL-2 critical for driving their proliferation and survival. Moreover, these studies revealed a critical level of donor-Treg engraftment was required for tolerance induction to skin transplants. These mouse studies lay the foundation for development of novel Treg approaches for tolerance induction in the clinic involving not only organ or cellular transplantation, but also to re-establish self-tolerance in autoimmune settings. © Copyright 2014 The American Society of Transplantation and the American Society of Transplant Surgeons.

Entities:  

Keywords:  Cytokine; T cells; T regulatory cells; tolerance; transplantation

Mesh:

Substances:

Year:  2014        PMID: 24618297     DOI: 10.1111/ajt.12650

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  8 in total

1.  Adoptive T Regulatory Cell Therapy for Tolerance Induction.

Authors:  Cecilia Cabello-Kindelan; Shane Mackey; Allison L Bayer
Journal:  Curr Transplant Rep       Date:  2015-06-01

2.  Clinical intraocular islet transplantation is not a number issue.

Authors:  A Shishido; A Caicedo; R Rodriguez-Diaz; A Pileggi; P-O Berggren; M H Abdulreda
Journal:  CellR4 Repair Replace Regen Reprogram       Date:  2016-07-26

3.  Engineering an "infectious" T(reg) biomimetic through chemoselective tethering of TGF-β1 to PEG brush surfaces.

Authors:  E Y Yang; J P Kronenfeld; K M Gattás-Asfura; A L Bayer; C L Stabler
Journal:  Biomaterials       Date:  2015-07-14       Impact factor: 12.479

Review 4.  Engineering biomimetic materials for islet transplantation.

Authors:  Ethan Y Yang; Joshua P Kronenfeld; Cherie L Stabler
Journal:  Curr Diabetes Rev       Date:  2015

Review 5.  The Expanding Role of Natural Killer Cells in Type 1 Diabetes and Immunotherapy.

Authors:  Chris Fraker; Allison L Bayer
Journal:  Curr Diab Rep       Date:  2016-11       Impact factor: 4.810

6.  Immunomodulation Followed by Antigen-Specific Treg Infusion Controls Islet Autoimmunity.

Authors:  Cecilia Cabello-Kindelan; Shane Mackey; Alexander Sands; Jennifer Rodriguez; Claudia Vazquez; Alberto Pugliese; Allison L Bayer
Journal:  Diabetes       Date:  2019-11-11       Impact factor: 9.461

7.  The Induction and Maintenance of Transplant Tolerance Engages Both Regulatory and Anergic CD4+ T cells.

Authors:  Alix Besançon; Marije Baas; Tania Goncalves; Fabrice Valette; Herman Waldmann; Lucienne Chatenoud; Sylvaine You
Journal:  Front Immunol       Date:  2017-03-06       Impact factor: 7.561

8.  CCL21 Expression in β-Cells Induces Antigen-Expressing Stromal Cell Networks in the Pancreas and Prevents Autoimmune Diabetes in Mice.

Authors:  Freddy E Gonzalez Badillo; Flavia Zisi Tegou; Maria M Abreu; Riccardo Masina; Divya Sha; Mejdi Najjar; Shane H Wright; Allison L Bayer; Éva Korpos; Alberto Pugliese; R Damaris Molano; Alice A Tomei
Journal:  Diabetes       Date:  2019-08-01       Impact factor: 9.337

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.